Pi-Cardia logo — Leading the way for leaflet modification

Pi-Cardia

Leading the way for leaflet modification

Founded 2009 Israel Israel 59 employees Debt Financing Total: $58.00M Health Care, Medical Devices

General Information

Company Name Pi-Cardia
Founded Year 2009
Location Israel Israel +1
Founders / Decision Makers
Team member
Employees 59
Industries Health Care, Medical Devices
Funding Stage Debt Financing
Social

Get notified when Pi-Cardia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pi-Cardia

Pi-Cardia, a **medical device company** based in **Israel**, has positioned itself as a **market leader** in developing a diverse range of leaflet modification solutions for treating heart valves. The company boasts extensive knowledge and expertise in degenerated valves, including calcification patterns, mode of valve failure, and the impact of various leaflet modification methods. Their innovative solution, ShortCut™, has been designed to provide a **safe, simple, and effective** way to split leaflets of pre-existing valves, enabling Transcatheter Aortic Valve Replacement (TAVR) in patients at risk of coronary obstruction while assisting in preserving coronary access. Founded in **2009**, Pi-Cardia recently secured a significant **$21.00M Debt Financing** investment, termed as the "Pi investment," on **01 January 2021**. This investment reflects a strong belief in the company's potential to revolutionize the treatment of heart valve conditions and underscores the confidence in its product portfolio. The company's relentless pursuit of innovation in the **Health Care** sector positions it as an intriguing prospect for investors seeking to support transformative advancements in cardiovascular healthcare.

Taxonomy: Medical Device, Aortic Stenosis, Catheter System, Cardiovascular Treatment, Innovative Technology, Valve Calcification, Minimally Invasive Surgery, Medical Innovation, Non-surgical Treatment, Heart Health, Cardiology, Valve Fracture, Soft Tissue Preservation, Medical Start-up

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing - Pi •••••• - 01 Jan 2021
Venture Round - Pi •••••• 2
Investor
•••• ••••
20 Apr 2020
Series C - Pi •••••• 3
Investor Investor
•••• ••••
07 Jan 2016
Series C - Pi •••••• 1 •••• •••• 01 Sep 2015
Series B - Pi •••••• 1
Investor
01 Dec 2011

View All 6 Funding Rounds

Pi-Cardia Alternatives & Competitors

Pi-Cardia vs

Advanced transcatheter therapy for resilient heart health and optimal blood flow

Series Unknown
11-50 employees
Health Care, Health and Wellness
Pi-Cardia vs
Nyra Medical
Nyra Medical United States

Nyra Medical is a structural heart company focused on developing a first in class transcatheter valv...

Series A
17 employees
Medical Devices
Pi-Cardia vs
Flotech
Flotech United States

Valve & Automation Experts,US Southeast. VR Safety Valve Repair & Testing. Limitorque Blue Ribbon Se...

127 employees
Industrial, Manufacturing

FAQ About Pi-Cardia

Leading the way for leaflet modification
Pi-Cardia was founded in 2009.
Pi-Cardia is headquartered in Israel.
Pi-Cardia operates in the following industries: Health Care, Medical Devices.
Pi-Cardia has approximately 59 employees.
Pi-Cardia has completed 6 funding rounds, raising a total of $58.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Pi-Cardia include MVRx, Inc., Nyra Medical, Flotech, American Production Valve, Aira 4Matic Global Valve Automation Pvt. Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pi-Cardia and MVRx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pi-Cardia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy